Key facts
- President Trump announced Dr. Heidi Overton as his nominee to lead the Food and Drug Administration (FDA).
- Overton is a physician and senior health policy official on the White House Domestic Policy Council.
- She has worked with Trump and his allies since 2019.
- Overton was involved in drafting an executive order on childhood vaccines that was later blocked by a federal judge.
- Biopharmaceutical executives expressed cautious optimism for stability at the agency.
- Concerns were raised about potential political considerations influencing scientific decisions at the FDA.
President Donald Trump announced on Wednesday that he is nominating Dr. Heidi Overton to lead the U.S. Food and Drug Administration (FDA). Overton, described by Trump as a "ROCKSTAR" who is "SMART and RESPECTED by all!", is a physician and currently serves as a senior health policy official on the White House Domestic Policy Council. She has a history of working with Trump and his allies since 2019, including a stint as a White House fellow during the first Trump administration and time at the Trump-aligned America First Policy Institute.
Overton's involvement in policy decisions has drawn attention, including her role in drafting an executive order on childhood vaccines that was later blocked by a federal judge. Biopharmaceutical executives and investors have reacted with cautious optimism, hoping Overton will bring stability to the agency after a period of perceived turbulence. They expressed a desire for the agency's leadership to prioritize scientific considerations over political ones.
Trade groups like the Biotechnology Innovation Organization (BIO) echoed these hopes, stating their desire for a new commissioner to continue stabilizing the agency and meet patient needs. If confirmed by the Senate, Overton would succeed former commissioner Marty Makary, whose tenure was marked by complaints of mixed signals and shifting processes from biopharma leaders. Concerns have also been raised by some medical organizations regarding Overton's commitment to sound science, particularly in light of her involvement in the vaccine executive order.